Oncternal Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Oncternal Therapeutics shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Oncternal Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Oncternal Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Oncternal Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $1.6k | 1.2k | 1.32 |
2024-06-30 | $760 | 100 | 7.60 |
2024-03-31 | $900 | 100 | 9.00 |